Lincoln Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 169.34 | 161.30 | 155.52 |
| Operating Expense | 130.26 | 141.46 | 122.89 |
| Net Profit | 27.68 | 11.58 | 20.77 |
| Net Profit Margin | 16.35 | 7.18 | 13.36 |
| Earning Per Share | 13.82 | 5.78 | 10.37 |
| EBIDTA | 35.49 | 21.83 | 32.77 |
| Effective Tax Rate | 10.54 | 33.52 | 24.67 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 169.34 |
| Operating Expense | 130.26 |
| Net Profit | 27.68 |
| Net Profit Margin | 16.35 |
| Earning Per Share | 13.82 |
| EBIDTA | 35.49 |
| Effective Tax Rate | 10.54 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 623.23 | 580.55 | 510.31 |
| Operating Expenses Annual | 521.74 | 480.64 | 421.14 |
| Operating Profit Annual | 123.97 | 134.33 | 111.65 |
| Interest Annual | 1.88 | 1.46 | 2.03 |
| Depreciation | 12.80 | 10.52 | 9.05 |
| Net Profit Annual | 82.35 | 93.30 | 72.90 |
| Tax Annual | 26.84 | 28.94 | 27.56 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 623.23 |
| Operating Expenses Annual | 521.74 |
| Operating Profit Annual | 123.97 |
| Interest Annual | 1.88 |
| Depreciation | 12.80 |
| Net Profit Annual | 82.35 |
| Tax Annual | 26.84 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 5.31 | 4.58 | 6.57 |
| Cash Flow from Operations | 93.02 | 63.24 | 39.16 |
| Cash Flow from Investing | -78.95 | -57.34 | -36.64 |
| Cash Flow from Financing | -6.40 | -5.18 | -4.50 |
| Cash Flow at the End | 12.97 | 5.31 | 4.58 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 5.31 |
| Cash Flow from Operations | 93.02 |
| Cash Flow from Investing | -78.95 |
| Cash Flow from Financing | -6.40 |
| Cash Flow at the End | 12.97 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 19.89 | 23.14 | 21.88 |
| PBIT Margin (%) | 17.82 | 21.31 | 20.08 |
| PBT Margin (%) | 8.34 | 6.72 | 10.19 |
| Net PROFIT Margin (%) | 13.21 | 16.07 | 14.29 |
| Return On Networth / Equity (%) | 13.02 | 17.04 | 15.59 |
| Return On Networth /Employed (%) | 17.42 | 22.35 | 21.60 |
| Return On Assets (%) | 12.95 | 16.87 | 15.43 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.98 | 1.05 | 1.08 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 19.89 |
| PBIT Margin (%) | 17.82 |
| PBT Margin (%) | 8.34 |
| Net PROFIT Margin (%) | 13.21 |
| Return On Networth / Equity (%) | 13.02 |
| Return On Networth /Employed (%) | 17.42 |
| Return On Assets (%) | 12.95 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.98 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 181.97 | 179.33 | 150.53 |
| Total Current Assets Annual | 499.75 | 437.59 | 367.00 |
| Non Current Assets Annual | 297.12 | 262.56 | 220.26 |
| Total Shareholders Funds Annual | 671.67 | 592.84 | 502.47 |
| Total Assets Annual | 796.87 | 700.15 | 587.26 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 181.97 |
| Total Current Assets Annual | 499.75 |
| Non Current Assets Annual | 297.12 |
| Total Shareholders Funds Annual | 671.67 |
| Total Assets Annual | 796.87 |
EPS (INR)
Expected
13.82
Reported
13.82
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
